Cigna Group

CI Healthcare Healthcare Plans

Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

282.53 0.81 −0.29%
Market cap
$74.7B
P/E
11.7×
Fwd P/E
11.4×
Dividend yield
2.19%
F-score
8/9
Altman Z
2.62
Beneish M
−2.47
Dividend safety
82/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

9 8 8 8
ROE
14.58% 14.33% 15.18% 15.40%
ROA
3.90% 3.80% 4.14% 4.16%
ROIC
8.06% 8.76% 9.04% 9.09%
Return on Tangible Assets
(56.59%) (49.05%) (56.23%) (59.71%)
Average Days of Receivables
48.90 43.64 40.30 44.96
Free Cash Flow per Share
27.97 31.45 29.15 34.65
Free Cash Flow
7,437.00 8,389.00 7,660.00 9,113.00
Capital Expenditures
(1,227.00) (1,212.00) (1,152.00) (1,164.00)
Other line items
Cash ROIC
9.06% 10.36% 9.53% 11.24%
Accounts Receivable Turnover
7.85 8.94 8.97 8.04
Accounts Payable Turnover
0.94 0.87 0.87 0.85
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
399.15 435.59 409.42 411.99
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.18) (0.19) (0.20) (0.19)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
5.55% 5.32% 5.08% 5.02%
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Interest Coverage
6.41 6.53 6.83 7.00
Operating CF/Net income
1.41 1.61 1.40 1.60
Depreciation/Fixed assets
0.74 0.76 0.74 0.73
Capex/Depreciation
(0.45) (0.44) (0.42) (0.43)
Revenue per Share
1,008.14 1,030.58 1,057.65 1,073.75
Operating CF per Share
32.58 35.99 33.54 39.08
Capex per Share
(4.61) (4.54) (4.38) (4.43)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates